Clinical Trial Update: Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing carvedilol versus atorvastatin for prevention of contrast-induced nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• CARVEDILOL (Carvedilol)
• atorvastatin (atorvastatin)

Snippet

Sponsor: rabab ahmed mohamed | Conditions: Contrast-induced Nephropathy | Phase 2 | Status: COMPLETED